Patent applications published 7 September 2011
Selected patent applications from the weekly European Patents Bulletin
- Antiviral supplement formulation
Vymedic 2362725*
- Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions on the function of red cells
Edison Pharmaceuticals 2362726*
- Methods for treating resistant diseases using triazole containing macrolides
Cempra Pharmaceuticals 2362727*
- Releasable polymeric lipids for nucleic acids delivery system
Enzon Pharmaceuticals 2362728*
- Releasable polymeric lipids for nucleic acids delivery system
Enzon Pharmaceuticals 2362729*
- Adamantyl benzamide compounds
High Point Pharmaceuticals 2362730*
- Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
Merck Sharp & Dohme 2362731*
- Compsns and methods for treating or preventing radiation injury
The Johns Hopkins University 2362770*
- Combination therapy comprising DHODH inhibitor and methotrexate for treating autoimmune disease
ASC 2362771*
- Pharmaceutical association lipoic acid and hydroxycitric acid as active ingredients
Biorebus; Schwartz 2362772*
- Methods for inducing programmed cell death
Novogen Research 2362773*
- Anthelmintic compsns
Intervet International 2362774*
- Chemical compounds
GlaxoSmithKline 2362775*
- Cell compsns and uses thereof
Sportcell 2362776*
- Use of pharmaceutical compsns in preparing pharmaceuticals for treating diabetic ulcer
Xu, Rongxiang 2362777*
- Compsns comprising vitamins
Tutino, Matteo 2362778*
- CXCR4 receptor compounds
Anchor Therapeutics 2262779*
- Combination vaccine with acellular pertussis
Panacea Biotec 2362780*
- A vaccinia virus protein A46 peptide and use thereof
The Provost, Fellows, Foundation Scholars and other members of the board of the College of the Holy and Undivided Trinity of Queen Elizabeth 2362782*
- Light targeting molecules and uses thereof
Biogen Idec 2362783*
- Neurotensin-derived branched peptides and uses thereof
Bracci, Luisa; Pini, Alessandro; Falciani, Chiara; Menichetti, Stefano 2362784*
- Deuterated 2-propylpentanoic acid compounds
Concert Pharmaceuticals 2362865*
- Isoprenyl compounds and methods thereof
Signum Biosciences 2362866*
- Methods for making carbamates, ureas and isocyanates
SABIC Innovative Plastics 2362867*
- Process for the preparation of protective L-alanine derivatives
Janssen Pharmaceutica 2362868*
- Polymorphs
Generics( (UK) 2362869*
- Novel processes and pure polymorphs
Generics (UK) 2362870*
- Enhanced stability peracid compsns
Ecolab 2362871*
- Decahydro-1H-indenoquinolinone and decahydro-3H-cyclopentaphenanthridinone CYP17 inhibitors
BioMarin Pharmaceutical 2362872*
- New crystal form of Sunitinib malate
LEK Pharmaceuticals 2362873*
- Modulators of ATP-binding cassette transporters
Vertex Pharmaceuticals 2362874*
- Process for the production of alpha-tocotrienol and derivatives
Edison Pharmaceuticals 2362875*
- Thienotriazolodiazepine derivatives active on Apo A
Cricomed 2362876*
- Polynucleotides encoding a human trim-cyp fusion protein polypeptide, compsns thereof, and methods using same
The Trustees of Columbia University in the City of New York 2362877*
- APJ receptor compounds
Anchor Therapeutics 2362878*
- Anti-TNF-alpha fibronectin type III domain based scaffold compsns, methods and uses
Centocor Ortho Biotech 2362879*
- Tumour necrosis factor alpha inhibiting proteins and uses thereof
Panacea Biotec 2362880*
- CRHR2 peptide agonists and uses thereof
Janssen Pharmaceutica 2362881*
- Detecting antigen responsive cells in a sample
Stichting Sanquin Bloedvoorziening; Stichting Het Nederlands Kanker Instituut 2362882*
- Compsns and methods for engineering cells
Life Technologies Corp 2362912*
- Prognostic test for early stage non small cell lung cancer (NSCLC)
Abbott Laboratories 2362914*
- Bifidobacteria crispr sequences
Danisco 2362915*
- HPV types and variants associated with cervical cancer and the uses thereof
DDL Diagnostic Laboratory; Institut Catala D’Oncologia 2362916*
- Targeting enzymes of the TRNA splicing pathway for the identification of anti-fungal and/or antiproliferative molecules
PTC Therapeutics 2363025